However, a significant number of RA patients do not respond adequately to this treatment, become resistant to anti-TNF-α therapies or experience significant adverse side effects [19,20,48], indicating the participation of other cytokines in the pathogenesis of RA. The gene discussed is TNF; the disease is rheumatoid arthritis.